Citation profile for Diego Useche

Diego Useche : Citation Profile

Université de Rennes

H index

i10 index

Citations

RESEARCH PRODUCTION:

Articles

Papers

Chapters

RESEARCH ACTIVITY:

   8 years (2014 - 2022). See details.
   Cites by year: 6
   Journals where Diego Useche has often published
   Relations with other researchers
   Recent citing documents: 20.    Total self citations: 3 (5.17 %)

MORE DETAILS IN:

EconPapers

ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pus30
   Updated: 2024-11-08    RAS profile: 2024-03-08
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Lissoni, Francesco (6)

Miguelez, Ernest (6)

Authors registered in RePEc who have co-authored more than one work in the last five years with Diego Useche.

Is cited by:

Miguelez, Ernest (3)

de Rassenfosse, Gaétan (3)

GOXE, Francois (2)

Konstantios, Dimitrios (2)

Cantwell, John (2)

Konstantios, Dimitrios (2)

Morgan, Horatio (2)

Marino, Alba (1)

BELIN, Jean (1)

Quatraro, Francesco (1)

Dachs, Bernhard (1)

Cites to:

Hall, Bronwyn (8)

van Pottelsberghe de la Potter, Bruno (5)

Graham, Stuart (5)

Noel, Michael (5)

Harhoff, Dietmar (5)

Ritter, Jay (3)

Trajtenberg, Manuel (3)

welch, ivo (3)

Bessen, James (2)

Jaffe, Adam (2)

de Rassenfosse, Gaétan (2)

Main data

Where Diego Useche has published?

Journals with more than one article published	# docs
Small Business Economics	2

Working Papers Series with more than one paper published	# docs
Post-Print / HAL	15
Working Papers / HAL	3

Recent works citing Diego Useche (2024 and 2023)

Year	Title of citing document
2023	Relevancia, evolución y tendencias de la supervivencia empresarial. Una revisión de literatura en finanzas. (2023). Rojasberrio, Sandra Patricia ; Rincon, Diego Useche ; Arango, Paula Zuluaga. In: REVISTA TENDENCIAS. RePEc:col:000520:020634. Full description at Econpapers \|\| Download paper
2023	Smoke signal: When firms patent strategy and local patent protection system affect equity stakes in cross-border acquisitions. (2023). Jimenez, Alfredo ; Gnekpe, Christian. In: Journal of International Management. RePEc:eee:intman:v:29:y:2023:i:6:s1075425323000765. Full description at Econpapers \|\| Download paper
2023	Productivity gains from migration: Evidence from inventors. (2023). de Rassenfosse, Gaétan ; Piguet, Etienne ; Penner, Orion ; Pellegrino, Gabriele. In: Research Policy. RePEc:eee:respol:v:52:y:2023:i:1:s0048733322001524. Full description at Econpapers \|\| Download paper
2023	Leveraging global recombinant capabilities for green technologies: the role of ethnic diversity in MNEs’ dynamics. (2023). Quatraro, Francesco ; Marino, Alba. In: The Journal of Technology Transfer. RePEc:kap:jtecht:v:48:y:2023:i:4:d:10.1007_s10961-022-09975-5. Full description at Econpapers \|\| Download paper
2023	The timing dilemma: understanding the determinants of innovative startups’ patent collateralization for loans. (2023). Wu, Bingde ; Hu, Die ; Zhang, Hao ; Yang, Xue. In: Small Business Economics. RePEc:kap:sbusec:v:60:y:2023:i:1:d:10.1007_s11187-022-00645-2. Full description at Econpapers \|\| Download paper
2023	What drives the valuation of entrepreneurial ventures? A map to navigate the literature and research directions. (2023). Vismara, Silvio ; Montanaro, Benedetta ; Colombo, Massimo G. In: Small Business Economics. RePEc:kap:sbusec:v:61:y:2023:i:1:d:10.1007_s11187-022-00688-5. Full description at Econpapers \|\| Download paper
2023	Third-party signals in crowdfunded microfinance: which microfinance institutions boost crowdfunding among refugee entrepreneurs?. (2023). Duarte, Fabio ; Augusto, Mario ; Correia, Ricardo Emanuel ; Matias, Ana Paula. In: Small Business Economics. RePEc:kap:sbusec:v:61:y:2023:i:2:d:10.1007_s11187-022-00708-4. Full description at Econpapers \|\| Download paper
2023	Towards an evolutionary economic geography research agenda to study migration and innovation. (2023). Morrison, Andrea. In: Cambridge Journal of Regions, Economy and Society. RePEc:oup:cjrecs:v:16:y:2023:i:3:p:529-542.. Full description at Econpapers \|\| Download paper
2023	How do top management team characteristics affect government R&D subsidy grants? Evidence from an information economics perspective. (2023). Li, LI ; Wang, Yuandi ; Hu, Die ; She, Maoyan. In: Asian Business & Management. RePEc:pal:abaman:v:22:y:2023:i:1:d:10.1057_s41291-021-00168-w. Full description at Econpapers \|\| Download paper
2023	Signaling Theory in Entrepreneurship Research: A Systematic Review and Research Agenda. (2023). Kleinert, Simon ; Bafera, Julian. In: Entrepreneurship Theory and Practice. RePEc:sae:entthe:v:47:y:2023:i:6:p:2419-2464. Full description at Econpapers \|\| Download paper
2023	Prediction of patent grant and interpreting the key determinants: an application of interpretable machine learning approach. (2023). Ni, HE ; Yao, LI. In: Scientometrics. RePEc:spr:scient:v:128:y:2023:i:9:d:10.1007_s11192-023-04736-z. Full description at Econpapers \|\| Download paper

Works by Diego Useche:

Year	Title	Type	Cited
2014	Are patents signals for the IPO market? An EU–US comparison for the software industry In: Research Policy. [Full Text][Citation analysis]	article	22
2014	Are patents signals for the IPO market? An EU–US comparison for the software industry.(2014) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 22	paper
2016	Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies In: Post-Print. [Citation analysis]	paper	0
2015	Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies.(2015) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 0	paper
2018	Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies.(2018) In: NBER Chapters. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0	chapter
2017	Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies..(2017) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0	paper
2016	Empirical economic analysis of orphan drug legislation impact on innovation In: Post-Print. [Citation analysis]	paper	0
2016	Empirical Economic Analysis of Orphan Drug Legislation Impact on Innovation.(2016) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 0	paper
2016	Empirical Economic Analysis of Orphan Drug Innovation In: Post-Print. [Citation analysis]	paper	0
2017	Empirical Economic Analysis of Orphan Drug Innovation.(2017) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 0	paper
2016	Empirical Economic Analysis of Orphan Drug Innovation.(2016) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 0	paper
2020	Highly-skilled migrants and Cross-border M&A: Firm-level evidence In: Post-Print. [Citation analysis]	paper	11
2017	Highly-skilled migrants and Cross-border M&A: Firm-level evidence.(2017) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 11	paper
2018	Highly-skilled migrants and Cross-border M&A: Firm-level evidence.(2018) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 11	paper
2020	Highly-skilled migrants and Cross-border M&A: Firm-level evidence.(2020) In: Post-Print. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 11	paper
2021	Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms In: Post-Print. [Full Text][Citation analysis]	paper	1
2021	Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms.(2021) In: Small Business Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 1	article
2020	Highly skilled and well connected: Migrant inventors in cross-border M&As In: Post-Print. [Citation analysis]	paper	13
2021	Highly skilled and well connected: Migrant inventors in cross-border M&As.(2021) In: Working Papers. [Citation analysis] This paper has nother version. Agregated cites: 13	paper
2021	Highly skilled and well connected: Migrant inventors in cross-border M&As.(2021) In: Working Papers. [Citation analysis] This paper has nother version. Agregated cites: 13	paper
2020	Highly skilled and well connected: Migrant inventors in cross-border M&As.(2020) In: Journal of International Business Studies. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 13	article
2022	Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital In: Post-Print. [Citation analysis]	paper	5
2022	Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital.(2022) In: Small Business Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 5	article
2017	Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021. In: Working Papers. [Citation analysis]	paper	0
2015	Patenting Behaviour and the Survival of Newly Listed European Software Firms In: Industry and Innovation. [Full Text][Citation analysis]	article	3